Feb. 26 (UPI) -- The Food and Drug Administration's vaccine committee on Friday recommended Johnson & Johnson's coronavirus vaccine, one of the final steps in approving it for emergency use in the United States.
The FDA's Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend that the FDA grant the vaccine an emergency use authorization. The FDA must make a final determination before granting the EUA and and distributing it for use.